How Amgen uses Infinitus to support patient access and reimbursement For patients starting a new therapy, speed matters. Delays in access aren’t just logistical issues; they’re barriers that can jeopardize outcomes and undermine patient trust. Amgen’s U.S. Patient Access & Reimbursement (PAR) team is addressing this challenge with AI. By partnering with Infinitus to automate the benefit verification process, the team is helping providers and patients receive coverage information more quickly, sometimes within hours instead of days. Traditionally, verifying benefits could take the Amgen team up to five days. Today, thanks to Infinitus, our AI agent Eva, and expanded automation, Amgen now aims to provide answers to patients within 48 hours, often even sooner, but this will depend on payer response times. As a result, more patients can now receive coverage information faster. Continue reading the full story on Amgen’s website.